The influence of Galactomannan detection on tube feeding ß-galactomannan in critically ill patients: a prospective randomized controlled clinical trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049888

Enrollment

Unknown

Registered

2021-08-10

Start date

2021-10-01

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critically ill

Interventions

Experimental group:tube feeding ß-galactomannan

Control Group:No

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old; 2. Admission to ICU; 3. Those who need enteral nutrition support for more than 3 days; 4. The informed consent has been signed.

Exclusion criteria

Exclusion criteria: 1. Pregnant women; 2. Active gastrointestinal bleeding; 3. Stomach malignant tumor, peptic ulcer or mechanical intestinal obstruction; 4. Has been diagnosed with fungal infection.

Design outcomes

Primary

Measure	Time frame
Galactomannan detection;	—

Countries

China

Contacts

Public ContactChen Weisheng

Huizhou Third People's Hospital

hzsyeicu@outlook.com+86 13516666656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026